Vimarsana
Biggest News Aggregation in the World

Therapy Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapy Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapy Summit Today - Breaking & Trending Today

REGENXBIO Announces Presentation at the Barclays Gene Editing & Therapy Summit 2023 - Vimarsana News

REGENXBIO Announces Presentation at the Barclays Gene Editing & Therapy Summit 2023

ROCKVILLE, Md., May 22, 2023 /PRNewswire/ -- REGENXBIO Inc. today announced that it will present in a fireside chat and panel as well as host one-on-one investor meetings at the Barclays Gene... | May 22, 2023

Beam Therapeutics to Participate in Upcoming May Investor Conferences - Vimarsana News

Beam Therapeutics to Participate in Upcoming May Investor Conferences

CAMBRIDGE, Mass., May 17, 2023 -- Beam Therapeutics Inc. , a biotechnology company developing precision genetic medicines through base editing, today announced that management plans to participate... | May 17, 2023

Intellia Therapeutics, Inc.: Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress - Vimarsana News

Intellia Therapeutics, Inc.: Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress

Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to submit IND

Muscular Dystrophy Association Announces Nearly $400K in - Vimarsana News

Muscular Dystrophy Association Announces Nearly $400K in

New York, NY, March 13, 2023 (GLOBE NEWSWIRE) -- Today, Muscular Dystrophy Association (MDA) announced two research grants designed to address potential...

NeuroSense Announces Third Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

NeuroSense Announces Third Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...